Sleeve Gastrectomy Induced Remission of Slowly Progressive Type 1 Diabetes in a Morbidly Obese Japanese Patient

被引：5

作者：

Hironaka, Un-ya ^{[1
]}

Kitahama, Seiichi ^{[2
]}

Sato, Hiroyuki ^{[1
]}

Inoue, Maki ^{[1
]}

Takahashi, Tetsuya ^{[1
]}

Tamori, Yoshikazu ^{[1
,3
]}

机构：

[1] Chibune Gen Hosp, Dept Internal Med, Div Diabet & Endocrinol, Osaka, Japan

[2] Chibune Gen Hosp, Dept Bariatr & Metab Surg, Osaka, Japan

[3] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Dept Internal Med, Kobe, Hyogo, Japan

来源：

INTERNAL MEDICINE | 2019年 / 58卷 / 05期

关键词：

type; 1; diabetes; morbid obesity; bariatric surgery; TUMOR-NECROSIS-FACTOR; BARIATRIC SURGERY; INTERFERON-GAMMA; DESTRUCTION; CYTOKINES;

D O I：

10.2169/internalmedicine.1217-18

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The effects of bariatric/metabolic surgery on glycemic control in obese type 1 diabetic patients are controversial. We herein report a case of a morbidly obese 35-year-old woman who completely recovered from slowly progressive type 1 diabetes (SPIDDM) following laparoscopic sleeve gastrectomy. Preoperatively, her body mass index (BMI) was 49.8 kg/m(2) and hemoglobin Ale was 5.7% with intensive insulin therapy. Six months after bariatric/metabolic surgery, her BMI decreased to 33.2 kg/m(2) and her glycemic control was normal despite the discontinuation of all diabetic medicine. This case demonstrates the usefulness of bariatric/metabolic surgery for achieving glycemic control in morbidly obese patients with SPIDDM in Japan.

引用

页码：675 / 678

页数：4

共 22 条

[11] DESTRUCTION OF RAT ISLET CELL MONOLAYERS BY CYTOKINES - SYNERGISTIC INTERACTIONS OF INTERFERON-GAMMA, TUMOR NECROSIS FACTOR, LYMPHOTOXIN, AND INTERLEUKIN-1 [J].

PUKEL, C ;

BAQUERIZO, H ;

RABINOVITCH, A .

DIABETES, 1988, 37 (01) :133-136

[12] Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus [J].

Rabinovitch, A ;

Suarez-Pinzon, WL .

BIOCHEMICAL PHARMACOLOGY, 1998, 55 (08) :1139-1149

[13] Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes [J].

Schauer, Philip R. ;

Bhatt, Deepak L. ;

Kirwan, John P. ;

Wolski, Kathy ;

Aminian, Ali ;

Brethauer, Stacy A. ;

Navaneethan, Sankar D. ;

Singh, Rishi P. ;

Pothier, Claire E. ;

Nissen, Steven E. ;

Kashyap, Sangeeta R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :641-651

[14]

Scheen AJ, 1996, DIABETES METAB, V22, P397

[15] Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Type 2 Diabetes Mellitus [J].

Seki, Yosuke ;

Kasama, Kazunori ;

Umezawa, Akiko ;

Kurokawa, Yoshimochi .

OBESITY SURGERY, 2016, 26 (09) :2035-2044

[16]

Tateya Sanshiro, 2013, Front Endocrinol (Lausanne), V4, P93, DOI 10.3389/fendo.2013.00093

[17] Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies [J].

Tuomi, T ;

Carlsson, Å ;

Li, HY ;

Isomaa, B ;

Miettinen, A ;

Nilsson, A ;

Nissén, M ;

Ehrnström, BO ;

Forsén, B ;

Snickars, B ;

Lahti, K ;

Forsblom, C ;

Saloranta, C ;

Taskinen, MR ;

Groop, LC .

DIABETES, 1999, 48 (01) :150-157

[18]

Uno K, 2017, ASIAN J ENDOSC SURG

[19] Long-Term Outcomes in Patients with Morbid Obesity and Type 1 Diabetes Undergoing Bariatric Surgery [J].

Vilarrasa, Nuria ;

Rubio, Miguel Angel ;

Minambres, Inka ;

Flores, Lillian ;

Caixas, Assumpta ;

Ciudin, Andrea ;

Bueno, Marta ;

Garcia-Luna, Pedro Pablo ;

Ballesteros-Pomar, Maria D. ;

Ruiz-Adana, Marisol ;

Lecube, Albert .

OBESITY SURGERY, 2017, 27 (04) :856-863

[20] Cytokines in the Progression of Pancreatic β-Cell Dysfunction [J].

Wang, Chunjiong ;

Guan, Youfei ;

Yang, Jichun .

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2010, 2010

← 1 2 3 →